Gynecologic
Gynecologic
We’re here for you. Call us at 844-346-7222 or
find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.
4
Clinical Trials
Gynecologic
Phase II
Enrolling
nct/study# NCT04865887 / IIT-KHLEIF
A Phase II Trial of Combination Therapy of Pembrolizumab and Lenvatinib in Patients With Locally Advanced or Metastatic Cervical Cancer
Learn More
Gynecologic
Phase II/III
Enrolling
nct/study# NCT05256225 / NRG-GY026-JTCC
A Phase II/III study of paclitaxel/carboplatin alone or combined with either trastuzumab and hyaluronidase-oysk (HERCEPTIN HYLECTA) or pertuzumab trastuzumab and hyaluronidase-zzfx (PHESGO) in HER2 positive, stage I-IV endometrial serous carcinoma or carcinosarcom
Learn More
Gynecologic
N/A
Enrolling
nct/study# N/A / PRO00006051
Feasibility and Clinical Significance of Sentinel Lymph Node Dissection in Endometrial Cancer Staging
Learn More
Gynecologic
Phase II
Enrolling
nct/study# NCT05548296 / ACR-368-201
A Phase 1b/2 Basket Study of ACR-368 as Monotherapy and in Combination with Gemcitabine in Adult Subjects with Platinum-Resistant Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma Based on Acrivon OncoSignature® Status
Learn MoreWe are here for you
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.